Han Chun-Ya E, Wang Youping, Yu Longchuan, Powers David, Xiong Xiaoling, Yu Violeta, Nguyen Yen, Jean David J St, Babij Philip
Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
Bioorg Med Chem Lett. 2009 Mar 1;19(5):1442-5. doi: 10.1016/j.bmcl.2009.01.025. Epub 2009 Jan 15.
A chemical screen of 45,000 compounds from a diverse collection led to the identification of two series of small molecules with potent osteogenic activity in mouse MC3T3-E1 osteoblast cells. The first chemical group was characterized by an amino benzothiazole core (AMG0892 series) and the second group by a naphthyl amide core (AMG0309 series). Using alkaline phosphatase (ALP), osteocalcin (OCL) and calcium as markers of osteoblast differentiation and mineralization, both chemical series showed EC(50)s in the 0.01-0.2 microM range and were consistent for all three markers. Compounds inhibited cell proliferation, had no effect on apoptosis and showed evidence for CREB pathway activity. The present compounds represent some of the most potent osteogenic small molecules reported to date and provide new tools for elucidating signaling mechanisms in osteoblasts.
对来自不同化合物库的45000种化合物进行化学筛选,结果鉴定出在小鼠MC3T3-E1成骨细胞中具有强大成骨活性的两个系列小分子。第一类化学基团以氨基苯并噻唑为核心(AMG0892系列),第二类以萘酰胺为核心(AMG0309系列)。以碱性磷酸酶(ALP)、骨钙素(OCL)和钙作为成骨细胞分化和矿化的标志物,两个化学系列的半数有效浓度(EC50)均在0.01 - 0.2微摩尔范围内,并且在所有三个标志物上表现一致。化合物抑制细胞增殖,对细胞凋亡无影响,并显示出CREB通路活性的证据。目前的这些化合物是迄今为止报道的一些最有效的成骨小分子,为阐明成骨细胞中的信号传导机制提供了新工具。